Akorn, Inc. Announces Certain Preliminary Financial Results for Q3 2013

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company (the “Company”), today announced certain preliminary financial results for its third quarter ended September 30, 2013. The purpose of this release is to facilitate the syndication of a $600 million term loan related to the Company’s previously announced acquisition of Hi-Tech Pharmacal Co., Inc. The acquisition is expected to close during the first quarter of 2014.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC